About Dxome
-
Overview
Dxome Co., Ltd. is a leader in molecular diagnostics, specializing in cancer and rare diseases. Utilizing Next Generation Sequencing (NGS) technology through minimally-invasive liquid biopsy, we integrate innovative proprietary reagents and bioinformatics solutions to develop a robust portfolio for personalized treatment selection, monitoring, and early detection, ensuring the highest quality products for clinical settings.
-
Mission
Our mission is to transform patient care by providing precise, actionable insights. We aim to redefine global healthcare with cutting-edge NGS-based solutions that elevate patient outcomes. Through continuous innovation, we strive to offer products that enable healthcare providers to deliver personalized treatments.
-
Goals
We try to lead the future of personalized medicine by ensuring the highest standards of accuracy and reliability in our products. Our goal is to enhance the quality of life for patients worldwide through ongoing innovation in personalized treatment selection, monitoring, and early detection. By advancing our comprehensive portfolio, we aim to provide clinicians with the tools necessary for precise and effective cancer care.
